Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models

Proteomics - Clinical Applications

Volumn 2, Issue 5, 2008, Pages 670-684

  Jain, Mohit Raja ^a   Ge, Wei Wen ^a,b   Elkabes, Stella ^a,c   Li, Hong ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Applied Biosystems   (United States)

^c Neurology Service   (United States)

Author keywords

Amyotrophic lateral sclerosis; Protein folding; Spinal cord; Superoxide dismutase

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CHAPERONE; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTATIN C; DYNACTIN; HEAT SHOCK COGNATE PROTEIN 71; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 4; HEAT SHOCK PROTEIN 70; MESSENGER RNA; MUTANT PROTEIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN 1; SENATAXIN; SYNAPSIN II; TRYPSIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; BINDING AFFINITY; CELL DEATH; CELL MEMBRANE TRANSPORT; CELL STRUCTURE; CEREBROSPINAL FLUID ANALYSIS; DISEASE ACTIVITY; EXPERIMENTAL ANIMAL; GENE MUTATION; GENETIC IDENTIFICATION; HUMAN; MASS SPECTROMETRY; METABOLIC DISORDER; MOTONEURON; NERVE CELL DEGENERATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; RNA SPLICING; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL;

ANIMALIA; MUS;

EID: 44649175712     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200780023     Document Type: Review

References (94)

1. Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A. et al., Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007, 10, 615-622.
2. Pasinelli, P., Brown, R. H., Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 2006, 7, 710-723.
3. Hensley, K., Mhatre, M., Mou, S., Pye, Q. N. et al., On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid. Redox Signal 2006, 8, 2075-2087.
4. Rakhit, R., Crow, J. P., Lepock, J. R., Kondejewski, L. H. et al., Monomeric Cu,Zn-superoxide dismutase is a common misfolding intermediate in the oxidation models of sporadic and familial amyotrophic lateral sclerosis. J. Biol. Chem. 2004, 279, 15499-15504.
5. Kanekura, K., Hashimoto, Y., Niikura, T., Aiso, S. et al., Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants. J. Biol. Chem. 2004, 279, 19247-19256.
6. Gonzalez de Aguilar, J. L., Echaniz-Laguna, A., Fergani, A., Rene, F. et al., Amyotrophic lateral sclerosis: all roads lead to Rome. J. Neurochem. 2007, 101, 1153-1160.
7. Nishimura, A. L., Mitne-Neto, M., Silva, H. C., Richieri-Costa, A. et al., A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004, 75, 822-831.
8. Chen, Y. Z., Bennett, C. L., Huynh, H. M., Blair, I. P. et al., DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 2004, 74, 1128-1135.
9. Duchen, L. W., Strich, S. J., A hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'wobbler'. J. Neurol. Neurosurg. Psychiatry 1968, 31, 535-542.
10. Schmitt-John, T., Drepper, C., Mussmann, A., Hahn, P. et al., Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse. Nat. Genet. 2005, 37, 1213-1215.
11. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A. et al., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362, 59-62.
12. Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C. et al., Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994, 264, 1772-1775.
13. Siddique, T., Deng, H. X., Genetics of amyotrophic lateral sclerosis. Hum. Mol. Genet. 1996, 5 Spec. No, 1465-1470.
14. Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K. et al., An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995, 14, 1105-1116.
15. Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L. et al., ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997, 18, 327-338.
16. Hirano, A., Kurland, L. T., Sayre, G. P., Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch. Neurol. 1967, 16, 232-243.
17. Dal Canto, M. C., Gurney, M. E., Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 1994, 145, 1271-1279.
18. Dal Canto, M. C., Gurney, M. E., A low expressor line of transgenic mice carrying a mutant human Cu,Zn superoxide dismutase (SOD1) gene develops pathological changes that most closely resemble those in human amyotrophic lateral sclerosis. Acta Neuropathol. (Berl) 1997, 93, 537-550.
19. Howland, D. S., Liu, J., She, Y., Goad, B. et al., Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. USA 2002, 99, 1604-1609.
20. Jonsson, P. A., Graffmo, K. S., Andersen, P. M., Brannstrom, T. et al., Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain 2006, 129, 451-464.
21. Morrison, B. M., Gordon, J. W., Ripps, M. E., Morrison, J. H., Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: neurochemical correlates of selective vulnerability. J. Comp. Neurol. 1996, 373, 619-631.
22. Groeneveld, G.J., Veldink, J.H., van der Tweel, I., Kalmijn, S. et al., A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Ann. Neurol. 2003, 53, 437-445.
23. Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B. et al., Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 1999, 5, 347-350.
24. Zhang, W., Narayanan, M., Friedlander, R. M., Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS. Ann. Neurol. 2003, 53, 267-270.
25. Bar, P. R., Motor neuron disease in vitro: the use of cultured motor neurons to study amyotrophic lateral sclerosis. Eur. J. Pharmacol. 2000, 405, 285-295.
26. Silani, V., Braga, M., Botturi, A., Cardin, V. et al., Human developing motor neurons as a tool to study ALS. Amyotroph. Lateral Scler. Other Motor Neuron. Disord. 2001, 2 Suppl 1, S69-S76.
27. Cashman, N. R., Durham, H. D., Blusztajn, J. K., Oda, K. et al., Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992, 194, 209-221.
28. Gal, J., Strom, A. L., Kilty, R., Zhang, F., Zhu, H., p62 accumulates and enhances aggregate formation in model systems of familial amyotrophic lateral sclerosis. J. Biol. Chem. 2007, 282, 11068-11077.
29. Chi, L., Ke, Y., Luo, C., Gozal, D., Liu, R., Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience 2007, 144, 991-1003.
30. Lino, M. M., Schneider, C., Caroni, P., Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 2002, 22, 4825-4832.
31. Pramatarova, A., Laganiere, J., Roussel, J., Brisebois, K., Rouleau, G. A., Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 2001, 21, 3369-3374.
32. Wang, J., Xu, G., Slunt, H. H., Gonzales, V. et al., Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol. Dis. 2005, 20, 943-952.
33. Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L. et al., Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003, 302, 113-117.
34. Domon, B., Aebersold, B., Mass spectrometry and protein analysis. Science 2006, 312, 212-217.
35. Ong, S. E., Mann, M., Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 2005, 1, 252-262.
36. Beghi, E., Mennini, T., Basic and clinical research on amyotrophic lateral sclerosis and other motor neuron disorders in Italy: recent findings and achievements from a network of laboratories. Neurol. Sci. 2004, 25 Suppl 2, S41-S60.
37. Atkin, J. D., Farg, M. A., Turner, B. J., Tomas, D. et al., Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J. Biol. Chem. 2006, 281, 30152-30165.
38. Uehara, T., Nakamura, T., Yao, D., Shi, Z. Q. et al., S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 2006, 441, 513-517.
39. Yamashita, H., Kawamata, J., Okawa, K., Kanki, R. et al., Heat-shock protein 105 interacts with and suppresses aggregation of mutant Cu/Zn superoxide dismutase: clues to a possible strategy for treating ALS. J. Neurochem. 2007, 102, 1497-1505.
40. Choi, J. S., Cho, S., Park, S. G., Park, B. C., Lee, D. H., Cochaperone CHIP associates with mutant Cu/Zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes. Biochem. Biophys. Res. Commun. 2004, 321, 574-583.
41. Niwa, J., Ishigaki, S., Hishikawa, N., Yamamoto, M. et al., Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. J. Biol. Chem. 2002, 277, 36793-36798.
42. Ishigaki, S., Niwa, J., Yamada, S., Takahashi, M. et al., Dorfin-CHIP chimeric proteins potently ubiquitylate and degrade familial ALS-related mutant SOD1 proteins and reduce their cellular toxicity. Neurobiol. Dis. 2007, 25, 331-341.
43. Miyazaki, K., Fujita, T., Ozaki, T., Kato, C. et al., NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1. J. Biol. Chem. 2004, 279, 11327-11335.
44. Liu, J., Shinobu, L. A., Ward, C. M., Young, D., Cleveland, D. W., Elevation of the Hsp70 chaperone does not effect toxicity in mouse models of familial amyotrophic lateral sclerosis. J. Neurochem. 2005, 93, 875-882.
45. Kiaei, M., Kipiani, K., Petri, S., Chen, J. et al., Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener. Dis. 2005, 2, 246-254.
46. Browne, S. E., Yang, L., DiMauro, J. P., Fuller, S. W. et al., Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol. Dis. 2006, 22, 599-610.
47. Choi, J., Rees, H. D., Weintraub, S. T., Levey, A. I. et al., Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases. J. Biol. Chem. 2005, 280, 11648-11655.
48. Ezzi, S. A., Urushitani, M., Julien, J. P., Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J. Neurochem. 2007, 102, 170-178.
49. Urushitani, M., Sik, A., Sakurai, T., Nukina, N. et al., Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 2006, 9, 108-118.
50. Hu, J. H., Chernoff, K., Pelech, S., Krieger, C., Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over-expressing mice. J. Neurochem. 2003, 85, 422-431.
51. Dewil, M., dela Cruz, V. F., Van Den Bosch, L, Robberecht, W., Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol. Dis. 2007, 26, 332-341.
52. Nguyen, M. D., Lariviere, R. C., Julien, J. P., Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron 2001, 30, 135-147.
53. Canete-Soler, R., Schwartz, M. L., Hua, Y., Schlaepfer, W. W., Stability determinants are localized to the 3′-untranslated region and 3′-coding region of the neurofilament light subunit mRNA using a tetracycline-inducible promoter. J. Biol. Chem. 1998, 273, 12650-12654.
54. Canete-Soler, R., Wu, J., Zhai, J., Shamim, M., Schlaepfer, W. W., p190RhoGEF Binds to a destabilizing element in the 3′ untranslated region of light neurofilament subunit mRNA and alters the stability of the transcript. J. Biol. Chem. 2001, 276, 32046-32050.
55. Ge, W., Wu, J., Zhai, J., Nie, Z. et al., Binding of p190RhoGEF to a destabilizing element on the light neurofilament mRNA is competed by BC1 RNA. J. Biol. Chem. 2002, 277, 42701-42705.
56. Canete-Soler, R., Reddy, K. S., Tolan, D. R., Zhai, J., Aldolases a and C are ribonucleolytic components of a neuronal complex that regulates the stability of the light-neurofilament mRNA. J. Neurosci. 2005, 25, 4353-4364.
57. Stefanizzi, I., Canete-Soler, R., Coregulation of light neurofilament mRNA by poly(A)-binding protein and aldolase C: implications for neurodegeneration. Brain Res. 2007, 1139, 15-28.
58. Ge, W. W., Volkening, K., Leystra-Lantz, C., Jaffe, H., Strong, M. J., 14-3-3 protein binds to the low molecular weight neurofilament (NFL) mRNA 3′ UTR. Mol. Cell. Neurosci. 2007, 34, 80-87.
59. Strong, M. J., Volkening, K., Hammond, R., Yang, W. et al., TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 2007, 35, 320-327.
60. Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C. et al., Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314, 130-133.
61. Ge, W. W., Leystra-Lantz, C., Sanelli, T. R., McLean, J. et al., Neuronal tissue-specific ribonucleoprotein complex formation on SOD1 mRNA: alterations by ALS SOD1 mutations. Neurobiol. Dis. 2006, 23, 342-350.
62. Ekegren, T., Hanrieder, J., Aquilonius, S. M., Bergquist, J., Focused proteomics in post-mortem human spinal cord. J. Proteome Res. 2006, 5, 2364-2371.
63. Pasinetti, G. M., Ungar, L. H., Lange, D. J., Yemul, S. et al., Identification of potential CSF biomarkers in ALS. Neurology 2006, 66, 1218-1222.
64. Ranganathan, S., Williams, E., Ganchev, P., Gopalakrishnan, V. et al., Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 2005, 95, 1461-1471.
65. Irani, D. N., Anderson, C., Gundry, R., Cotter, R. et al., Cleavage of cystatin C in the cerebrospinal fluid of patients with multiple sclerosis. Ann. Neurol. 2006, 59, 237-247.
66. Carrette, O., Burkhard, P. R., Hughes, S., Hochstrasser, D. F., Sanchez, J. C., Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process? Proteomics 2005, 5, 3060-3065.
67. Hansson, S. F., Simonsen, A. H., Zetterberg, H., Andersen, O. et al., Cystatin C in cerebrospinal fluid and multiple sclerosis. Ann. Neurol. 2007, 62, 193-196.
68. Fukada, K., Zhang, F., Vien, A., Cashman, N. R., Zhu, H., Mitochondrial proteomic analysis of a cell line model of familial amyotrophic lateral sclerosis. Mol. Cell. Proteomics 2004, 3, 1211-1223.
69. Becker, K. F., Schott, C., Hipp, S., Metzger, V. et al., Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J. Pathol. 2007, 211, 370-378.
70. Chaudhuri, T. K., Paul, S., Protein-misfolding diseases and chaperone-based therapeutic approaches. FEBS J. 2006, 273, 1331-1349.
71. Massignan, T., Casoni, F., Basso, M., Stefanazzi, P. et al., Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem. Biophys. Res. Commun. 2007, 353, 719-725.
72. Strey, C. W., Spellman, D., Stieber, A., Gonatas, J. O. et al., Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. Am. J. Pathol. 2004, 165, 1701-1718.
73. Allen, S., Heath, P. R., Kirby, J., Wharton, S. B. et al., Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. J. Biol. Chem. 2003, 278, 6371-6383.
74. Poon, H. F., Hensley, K., Thongboonkerd, V., Merchant, M. L. et al., Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2005, 39, 453-462.
75. Perluigi, M., Fai Poon, H., Hensley, K., Pierce, W. M. et al., Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2005, 38, 960-968.
76. Casoni, F., Basso, M., Massignan, T., Gianazza, E. et al., Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis. J. Biol. Chem. 2005, 280, 16295-16304.
77. Hu, J. H., Zhang, H., Wagey, R., Krieger, C., Pelech, S. L., Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. J. Neurochem. 2003, 85, 432-442.
78. de Beus, M. D., Chung, J., Colon, W., Modification of cysteine 111 in Cu/ Zn superoxide dismutase results in altered spectroscopic and biophysical properties. Protein Sci. 2004, 13, 1347-1355.
79. Zhang, H., Andrekopoulos, C., Joseph, J., Chandran, K. et al., Bicarbonate-dependent peroxidase activity of human Cu,Zn-superoxide dismutase induces covalent aggregation of protein: intermediacy of tryptophan-derived oxidation products. J. Biol. Chem. 2003, 278, 24078-24089.
80. Yamakura, F., Matsumoto, T., Fujimura, T., Taka, H. et al., Modification of a single tryptophan residue in human Cu,Zn-superoxide dismutase by peroxynitrite in the presence of bicarbonate. Biochim. Biophys. Acta 2001, 1548, 38-46.
81. Yamakura, F., Matsumoto, T., Ikeda, K., Taka, H. et al., Nitrated and oxidized products of a single tryptophan residue in human Cu,Zn-superoxide dismutase treated with either peroxynitrite-carbon dioxide or myeloperoxidase-hydrogen peroxide-nitrite. J. Biochem. (Tokyo) 2005, 138, 57-69.
82. Furukawa, Y., Fu, R., Deng, H. X., Siddique, T., O'Halloran, T. V., Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice. Proc. Natl. Acad. Sci. USA 2006, 103, 7148-7153.
83. Rakhit, R., Cunningham, P., Furtos-Matei, A., Dahan, S. et al., Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J. Biol. Chem. 2002, 277, 47551-47556.
84. Uchida, K., Kawakishi, S., Identification of oxidized histidine generated at the active site of Cu,Zn-superoxide dismutase exposed to H2O2. Selective generation of 2-oxo-histidine at the histidine 118. J. Biol. Chem. 1994, 269, 2405-2410.
85. Kurahashi, T., Miyazaki, A., Suwan, S., Isobe, M., Extensive investigations on oxidized amino acid residues in H(2)O(2)-treated Cu,Zn-SOd protein with LC-ESI-Q-TOF-MS, MS/MS for the determination of the copper-binding site J. Am. Chem. Soc. 2001, 123, 9268-9278.
86. Shinder, G. A., Lacourse, M. C., Minotti, S., Durham, H. D., Mutant Cu/ Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 2001, 276, 12791-12796.
87. Pasinelli, P., Belford, M. E., Lennon, N., Bacskai, B. J. et al., Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondría. Neuron 2004, 43, 19-30.
88. Agbas, A., Hui, D., Wang, X., Tek, V. et al., Activation of brain calcineurin (Cn) by Cu-Zn superoxide dismutase (SOD1) depends on direct SOD1-Cn protein interactions occurring in vitro and in vivo. Biochem. J. 2007, 405, 51-59.
89. Casareno, R. L., Waggoner, D., Gitlin, J. D., The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase. J. Biol. Chem. 1998, 273, 23625-23628.
90. Culotta, V. C., Klomp, L. W., Strain, J., Casareno, R. L. et al., The copper chaperone for superoxide dismutase. J. Biol. Chem. 1997, 272, 23469-23472.
91. Zhang, F., Strom, A. L., Fukada, K., Lee, S. et al., Interaction between familial ALS-linked SOD1 mutants and the dynein complex: Implications of retrograde axonal transport in ALS. J. Biol. Chem. 2007, 282, 16691-16699.
92. Okado-Matsumoto, A., Fridovich, I., Amyotrophic lateral sclerosis: a proposed mechanism. Proc. Natl. Acad. Sci. USA 2002, 99, 9010-9014.
93. Zhai, J., Lin, H., Canete-Soler, R., Schlaepfer, W. W., HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS. Hum. Mol. Genet. 2005, 14, 2629-2640.
94. Kunst, C. B., Mezey, E., Brownstein, M. J., Patterson, D., Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat. Genet. 1997, 15, 91-94.